News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Histogenics Corporation Raises $34 Million After ProChon Biotech Ltd. Merger



5/31/2011 7:46:02 AM

Histogenics Corp. brought in more than $34 million in equity and debt financing after its acquisition of fellow Bay State firm ProChon Biotech Ltd.

The two companies merged in an all-stock deal that brings ProChon CEO Patrick O'Donnell into the Histogenics corner office.

O'Donnell told MassDevice.com last week that a deal has been in the works since the early part of 2011.


Read at MassDevice


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES